Abstract
Part III provided a comprehensive, theoretical picture of the institutional barriers which are suggested to hinder the translation of personalized medicine into clinical practice. The identification of the barriers was based on a literature analysis, and the identification of the incentives for the stakeholders in the PM ecosystem was based on a theoretical microeconomic analysis. Part III is of general, theoretical value and can be tested in the context of other countries.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2018 Springer Fachmedien Wiesbaden GmbH, part of Springer Nature
About this chapter
Cite this chapter
Bosshard, K. (2018). Applied part. In: Law and Economics of Personalized Medicine. Gesundheitsmanagement und Gesundheitsökonomik. Springer Gabler, Wiesbaden. https://doi.org/10.1007/978-3-658-22074-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-658-22074-7_5
Published:
Publisher Name: Springer Gabler, Wiesbaden
Print ISBN: 978-3-658-22073-0
Online ISBN: 978-3-658-22074-7
eBook Packages: Economics and FinanceEconomics and Finance (R0)